Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Women's Screening and Self-Testing Program (PROMETA) Study
Sponsor: Tulane University
Summary
This proposal directly addresses the ability to safely scale-up a Screen-Triage-Treat approach to cervical cancer screening. The investigators propose to capitalize on a pool of screen-eligible women accessing routine care within targeted human immunodeficiency virus (HIV) care and treatment services. The primary outcome of interest is the number of women screened and the proportion of screen-positive women undergoing treatment. Secondary outcomes will focus on other implementation outcomes, and if successful, will be utilized to inform future research to take this approach to scale across Mozambique.
Official title: A Hybrid Type III Effectiveness - Implementation, Pragmatic Intervention Trial for Cervical Cancer Screen and Treat in Mozambique
Key Details
Gender
FEMALE
Age Range
25 Years - 49 Years
Study Type
INTERVENTIONAL
Enrollment
8445
Start Date
2026-01-01
Completion Date
2028-08-31
Last Updated
2025-12-17
Healthy Volunteers
No
Interventions
HPV DNA testing be self-collected vaginal swab
Directly following collection of the vaginal self-swab sample, the participant will be taken back to the waiting area and her sample will be taken to the laboratory for HPV testing using the Xpert HPV Test on the GeneXpert platform (Cepheid, Sunnyvale, CA, USA). This point-of-care test takes approximately 45 minutes to get results.
Locations (1)
University Eduardo Mondlane (UEM)
Maputo, Mozambique